Seagen SGEN
$ 228.74
0.0%
Quarterly report 2023-Q3
added 11-01-2023
Country |
USA |
IPO year |
2001 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Clay Siegall |
Employees in the company |
1 605 |
Shares |
185 M |
Market Cap[1] |
$ 42.2 B |
EBITDA (LTM) |
$ -800 M |
P/E (LTM) |
-50.56 |
P/S (LTM) |
17.34 |
EPS (LTM) |
-4.24 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.